ARTICLE | Distillery Therapeutics
Endocrine / Metabolic
November 14, 2017 10:57 PM UTC
Mouse studies suggest the FBN1 preprotein cleavage product asprosin could help treat neonatal progeroid syndrome, which is caused by FBN1 mutations, and inhibiting asprosin could help treat obesity. I...
BCIQ Company Profiles
BCIQ Target Profiles